COVID-19 PBMCs

HLA-typed peripheral blood mononuclear cells (PBMCs) from acute & recovered COVID-19 patients.

$500.00

Best Seller

COVID-19 PBMCs

HLA-typed peripheral blood mononuclear cells (PBMCs) from acute & recovered COVID-19 patients.

Product Description

Specifications

Size	10 or 100 million PBMCs
Estimated Lead Time	1-2 business days
Species	Human, SARS-CoV-2
Research Area	Infectious Disease, COVID-19
Shipping Type	Dry ice (additional shipping fee)

Available samples

E-mail info@raybiotech.com for a list of available samples

Sample Type

Peripheral blood mononuclear cells (PBMCs)

Characterized Markers

Major histocompatibility complex: HLA A, B, and C typed

Anticoagulant

EDTA

Format

Frozen with 10% DMSO

Storage temperature

Store in liquid nitrogen vapor phase

Biosafety Level

2
Note: While the patients were confirmed to have COVID-19 via a test detecting either SARS-CoV-2 virus or viral proteins using a nasopharyngeal swab, the PBMC samples have not been tested for the presence of virus or any other diseases and should be assumed infectious.

Featured Products

COVID-19 PBMCs

COVID-19 PBMCs

Product Description

Specifications

Featured Products

COVID-19 PBMCs

Product Description

Specifications

COVID-19 PBMCs

Featured Products

COVID-19 PBMCs

COVID-19 PBMCs

Product Description

Specifications

Reviews

Ask A Question

Featured Products

COVID-19 PBMCs

Product Description

Specifications

Reviews

Ask A Question

COVID-19 PBMCs